Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC828125066;25067;25068 chr2:178718165;178718164;178718163chr2:179582892;179582891;179582890
N2AB796424115;24116;24117 chr2:178718165;178718164;178718163chr2:179582892;179582891;179582890
N2A703721334;21335;21336 chr2:178718165;178718164;178718163chr2:179582892;179582891;179582890
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCA
  • RefSeq wild type template codon: CGT
  • Domain: Ig-68
  • Domain position: 18
  • Structural Position: 28
  • Q(SASA): 0.2053
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/E rs1474165122 -1.112 0.055 D 0.689 0.374 0.186928172975 gnomAD-2.1.1 8.22E-06 None None None None I None 0 0 None 0 0 None 6.55E-05 None 0 0 0
A/E rs1474165122 -1.112 0.055 D 0.689 0.374 0.186928172975 gnomAD-4.0.0 4.83065E-06 None None None None I None 0 0 None 0 0 None 0 0 0 4.30108E-05 0
A/T rs2077783832 None None N 0.183 0.211 0.0401082797425 gnomAD-4.0.0 1.61075E-06 None None None None I None 0 0 None 0 0 None 0 0 2.86054E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.4588 ambiguous 0.4356 ambiguous -0.903 Destabilizing 0.676 D 0.664 neutral None None None None I
A/D 0.7123 likely_pathogenic 0.8112 pathogenic -0.942 Destabilizing 0.214 N 0.739 prob.delet. None None None None I
A/E 0.5176 ambiguous 0.6234 pathogenic -0.937 Destabilizing 0.055 N 0.689 prob.neutral D 0.54967783 None None I
A/F 0.342 ambiguous 0.3706 ambiguous -0.793 Destabilizing 0.214 N 0.734 prob.delet. None None None None I
A/G 0.2845 likely_benign 0.3171 benign -1.094 Destabilizing 0.055 N 0.591 neutral N 0.494453239 None None I
A/H 0.6964 likely_pathogenic 0.7718 pathogenic -1.273 Destabilizing 0.864 D 0.689 prob.neutral None None None None I
A/I 0.1455 likely_benign 0.1217 benign -0.118 Destabilizing None N 0.461 neutral None None None None I
A/K 0.6177 likely_pathogenic 0.7173 pathogenic -1.159 Destabilizing 0.072 N 0.691 prob.neutral None None None None I
A/L 0.1356 likely_benign 0.134 benign -0.118 Destabilizing None N 0.405 neutral None None None None I
A/M 0.1826 likely_benign 0.1722 benign -0.188 Destabilizing 0.214 N 0.716 prob.delet. None None None None I
A/N 0.5371 ambiguous 0.6149 pathogenic -0.946 Destabilizing 0.214 N 0.735 prob.delet. None None None None I
A/P 0.8175 likely_pathogenic 0.8828 pathogenic -0.299 Destabilizing None N 0.467 neutral D 0.538321524 None None I
A/Q 0.5156 ambiguous 0.6084 pathogenic -1.018 Destabilizing 0.356 N 0.75 deleterious None None None None I
A/R 0.5227 ambiguous 0.6329 pathogenic -0.905 Destabilizing 0.214 N 0.751 deleterious None None None None I
A/S 0.1601 likely_benign 0.1813 benign -1.351 Destabilizing 0.012 N 0.551 neutral N 0.51971029 None None I
A/T 0.076 likely_benign 0.0736 benign -1.233 Destabilizing None N 0.183 neutral N 0.493199018 None None I
A/V 0.074 likely_benign 0.0642 benign -0.299 Destabilizing None N 0.227 neutral N 0.450539735 None None I
A/W 0.802 likely_pathogenic 0.8486 pathogenic -1.196 Destabilizing 0.864 D 0.722 prob.delet. None None None None I
A/Y 0.5939 likely_pathogenic 0.6507 pathogenic -0.749 Destabilizing 0.356 N 0.739 prob.delet. None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.